Recent GLP-1 coverage highlights nutrition and strength. Learn how to separate useful clinician guidance from universal rules and interpret lean-mass findings.
On September 27, 2026, The Times-Tribune published a feature about nutrition and exercise for people using GLP-1 medicines for weight loss. The article combined eating and hydration advice with strength-training guidance from physical therapist Paul J. Mackarey. Its central message was that treatment deserves attention beyond appetite reduction and the number on the scale.
That is a useful distinction for anyone trying to understand medication-supported weight management. Nutrition and movement are not tests of whether someone has earned treatment. In this coverage, they are supporting parts of care that deserve attention alongside a medicine's effects on hunger and fullness.
A 2026 Endocrine Reviews article provides the broader clinical context. It describes FDA obesity-medication indication language that pairs treatment with a reduced-calorie diet and increased physical activity. The review also frames obesity as a complex disease requiring treatment, rather than suggesting that lifestyle advice should replace medication.
The Times-Tribune describes several effects of GLP-1 medicines: reduced cravings, greater fullness and slower digestion. It also notes their role in helping control blood glucose. These effects help explain why eating may feel different during treatment and why nutrition deserves its own conversation.
Less hunger does not answer every question about food intake. In MedPage Today, physician Samantha Flanagan explains that appetite suppression can make it difficult to eat enough. The practical concern is therefore not simply whether someone is eating less. It is also whether they are meeting nutrition needs within the appetite they have.
This shifts the discussion away from restriction alone. A useful care conversation asks about appetite, food intake and energy rather than assuming that a smaller meal is always a better meal. Difficulty eating enough is a treatment-related concern to discuss, not a failure of motivation.
The Times-Tribune recommends attention to protein and suggests smaller meals and snacks. It also highlights hydration and gastrointestinal concerns such as constipation, nausea and heartburn. Those recommendations address the everyday experience of treatment, rather than treating weight change as a matter of willpower.
The feature connects activity with maintaining muscle and energy during weight reduction. Mackarey presents strength training as useful for strength and daily function, along with muscle and bone-density preservation. His emphasis broadens the goal from becoming lighter to supporting the body's capabilities.
At WeightRestart, that body-neutral perspective guides how we discuss weight management. Our resource on the relationship between exercise and appetite offers additional context for considering movement without reducing it to a way of compensating for food.
The Times-Tribune headline emphasizes diet and exercise. The article itself is a practical feature, not the announcement of a fully identified new clinical trial. Treating its recommendations as proof of one exact diet-and-training formula would give the coverage more certainty than its sourcing supports.
The feature refers to a recent study but does not identify its title or authors in the available text. It also does not establish the study design. That limits the ability to trace the complete package of advice to a particular piece of research.
MedPage Today reports that a four-organization advisory proposed a daily protein target between 1.2 and 1.6 grams per kilogram of body weight during active weight loss. The reporting presents this as a proposed target. It does not establish one ideal intake for every person or provide the advisory's underlying evidence grading.
The same coverage includes practical suggestions from individual clinicians. Flanagan recommends prioritizing the protein portion of a meal before vegetables and starches. Physician Allison Rhodes recommends spreading protein intake across meals and snacks.
These suggestions make the nutrition issue concrete: a person with less appetite may need help deciding how meals fit their needs. The appropriate next step is a discussion with the prescribing clinician about appetite and food intake. A generic calculation from an article should not become a personal nutrition prescription.
The exercise recommendations also vary between the reports. Mackarey suggests three weekly resistance-training sessions in The Times-Tribune. MedPage Today reports that Rhodes recommends a minimum of two resistance-training sessions per week. These are attributed practitioner recommendations rather than one universal schedule.
Mackarey's guidance emphasizes technique and gradual progression. He warns against turning training into a competition and describes injury concerns that include lower-back pain and muscle or tendon strain. The practical value is the emphasis on a well-designed program, not pressure to match someone else's starting point.
His article also advises medical clearance before starting exercise, particularly for people with conditions such as heart disease, hypertension or diabetes. It suggests that an orthopedic physical therapist may help tailor a program. Those are recommendations from his feature and belong in an individualized safety conversation.
Mackarey also advises stopping for symptoms such as pain, dizziness or lightheadedness. Persistent muscle or joint pain is another concern he identifies. For someone new to strength training, these points support discussing technique and symptoms with a qualified professional rather than copying a published routine.
The reality check is therefore more specific than a generic warning about media hype. The coverage supports taking nutrition and activity seriously. It does not support converting every clinician's preferred approach into a compulsory rule for every medication user.
MedPage Today's coverage gives a reason to discuss body composition alongside weight. It reports estimates that lean mass may account for 15% to 40% of GLP-1-associated weight loss. This is part of the concern behind the article's attention to protein and resistance training.
The report also describes an observational semaglutide study. In that study, lean mass represented 47.5% of weight lost among semaglutide users. The corresponding figure was 35.7% among participants receiving diet and lifestyle interventions alone.
The denominator matters here. These percentages describe the share of lost weight reported as lean mass. They do not describe the percentage of a person's entire body that was lost. Keeping that distinction visible helps prevent a striking figure from becoming a misleading description of treatment.
These figures are estimates and a reported observational finding, not predictions for an individual. The available coverage does not provide the observational study's authors or journal. It also omits the sample size and exact protein-intake thresholds. That prevents an independent assessment of its methods and generalizability from this reporting alone.
The terminology deserves care too. The reported outcome was lean mass, so it should not be relabeled as a precise measurement of muscle loss. An alarming claim about a fixed amount of muscle loss for every medication user would go beyond the evidence presented.
Rhodes offers a broader way to think about treatment goals. In MedPage Today, she emphasizes body composition and metabolic health alongside strength and function. The report also describes clinicians monitoring body composition in their practices, although those approaches are not presented as universal standards.
For a reader, the useful application is a more focused conversation with the prescribing team. Questions grounded in this coverage include:
These questions keep the discussion centered on nutrition, symptoms and capability. They also give the clinician a clearer picture than a weight reading alone. Personal decisions about food targets and exercise belong with qualified care rather than a generic article.
For a longer-term perspective, WeightRestart's resource on maintaining weight changes without constant dieting places maintenance within the wider discussion of sustainable habits.
The next useful studies would compare nutrition and activity approaches during medication-supported weight loss while measuring more than total weight change. Strength and daily function deserve attention alongside body composition. Research should also examine whether people can tolerate and sustain the approaches being tested.
Protein research would be more useful if it clarified which approaches suit different patients. Exercise research should compare practical training options rather than assume that one schedule fits everyone. Clear reporting of participants and methods would help clinicians judge how well findings apply to the people they treat.
What to watch next is whether better evidence turns these broad priorities into dependable clinical guidance. Before particular protein targets or training schedules become standard practice, research needs to show how they affect nutrition and function during treatment. The most valuable progress will be guidance that helps people remain adequately nourished and capable, not simply lighter.
WeightRestart shares research-led guidance on weight loss, metabolism, nutrition, strength, appetite, sleep and recovery. Our goal is to make complex health information clear, practical and useful for people building progress they can maintain.
Learn how to build a weight-management approach around better information, realistic expectations and habits you can keep using.
read the blog
